Effects of nitric oxide on blood flow distribution O2 extraction capabilities during endotoxic shock

Journal of Applied Physiology

Volumn 83, Issue 4, 1997, Pages 1164-1173

  Zhang, Haibo ^a   Rogiers, Peter ^a   Smail, Nadia ^a   Cabral, Ana ^a   Preiser, Jean Charles ^a   Peny, Marie Odile ^a   Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Cardiac output; Endothelium derived relaxing factor; Hypotension; Nitrite; Organ perfusion; Oxygen delivery; Sepsis; Tumor necrosis factor

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; LINSIDOMINE; N(G) METHYLARGININE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD FLOW; HEART OUTPUT; HYPOTENSION; KIDNEY BLOOD FLOW; LUNG ARTERY PRESSURE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0030802620     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1997.83.4.1164     Document Type: Article

References (41)

1. Ayuse, T., N. Brienza, J. P. Revelly, J. K. Boitnott, and J. L. Robotham. Role of nitric oxide in porcine liver circulation under normal and endotoxemic conditions. J. Appl. Physiol. 78: 1319-1329, 1995.
2. Booke, M., F. Hinder, R. McGuire, L. D. Traber, and D. L. Traber. Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep. Crit. Care Med. 24: 835-844, 1996.
3. Bordet, J. C., and M. Lagard. Modulation of prostacyclin/ thromboxane formation by molsidomine during platelet-endothelial cell interactions. Biochem. Pharmacol. 37: 3911-3914, 1988.
4. Boughton-Smith, N. K., I. R. Hucheson, and A. M. Deakin. Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur. J. Pharmacol. 191: 485-488, 1994.
5. Brady, A. J., P. A. Poole-Wilson, S. E. Harding, and J. B. Warren. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1963-H1966, 1992.
6. w-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J. Exp. Med. 176: 1175-1182, 1992.
7. Drazenovic, R., R. W. Samsel, M. E. Wylam, C. M. Doerschuk, and P. T. Schumacker. Regulation of perfused capillary density in canine intestinal mucosa during endotoxemia. J. Appl. Physiol. 72: 259-265, 1992.
8. Evans, T., A. Carpenter, H. Kinderman, and J. Cohen. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ. Shock 41: 77-81, 1993.
9. Fahey, T. J., III, T. Yoshioka, G. T. Shires, and G. A. Fantini. The role of tumor necrosis factor and nitric oxide in the acute cardiovascular response to endotoxin. Ann. Surg. 223: 63-69, 1996.
10. Florquin, S., Z. Amraoui, C. Dubois, J. Decuyper, and M. Goldman. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J. Exp. Med. 180: 1153-1158, 1994.
11. Fong, Y., M. A. Marano, and L. L. Moldawer. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J. Clin. Invest. 85: 1896-1904, 1990.
12. Grover, R., D. Zaccardelli, G. Colice, K. Guntupalli, D. Waston, and J.-L. Vincent. The cardiovascular effects of 546C88 in human septic shock (Abstract). Intensive Care Med. 21, Suppl.: S20, 1995.
13. Hinder, F., M. Booke, L. D. Traber, N. Matsumoto, K. Nishida, S. Rogers, and D. L. Traber. Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial natriuretic peptide. Crit. Care Med. 24: 131-136, 1996.
14. Hock, C. E., K. Yin, G. Yue, and P. Y. K. Wong. Effects of inhibition of nitric oxide synthase by aminoguanidine in acute endotoxemia. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H843-H850, 1997.
15. 2 uptake after inhibition of EDRF/NO synthesis. J. Appl. Physiol. 76: 1166-1171, 1994.
16. Klabunde, R. E., and A. F. Coston. Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock. Shock 3: 73-78, 1995.
17. Kumins, N. H., J. Hunt, R. L. Gamelli, and J. P. Filkins. Molsidomine increases endotoxic survival and decreases cytokine production. Shock 7: 200-205, 1997.
18. Kurose, I., R. Wolf, M. B. Grisham, and D. N. Granger. Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2224-H2231, 1995.
19. Meyer, J., F. Hinder, J. Stothert, Jr., L. D. Traber, D. N. Herndon, J. T. Flynn, and D. L. Traber. Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition. J. Appl. Physiol. 76: 2785-2793, 1994.
20. 2 delivery in septic dogs. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2017-H2023, 1995.
21. Moilanen, E., P. Vuorinen, H. Kankaanranta, T. Metsa-Ketela, and H. Vapaatalo. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br. J. Pharmacol. 109: 852-858, 1993.
22. Mulder, M. F., A. A. Van Lambalgen, E. Huisman, J. J. Visser, G. C. Van Den Bos, and L. G. Thijs. Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1558-H1564, 1994.
23. Nishida, J., R. S. McCuskey, D. McDonnell, and E. S. Fox. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am. J. Physiol. 267 (Gastrointest. Liver Physiol. 30): G1135-G1141, 1994.
24. Parker, J. L., and H. R. Adams. Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ. Res. 72: 539-551, 1993.
25. Pastor, C. M., M.-R. Losser, and D. Payen. Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits. Hepatology 22: 1547-1553, 1995.
26. Pastor, C. M., and D. M. Payen. Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxin shock model. Shock 2: 196-202, 1994.
27. 2+-independent nitric oxide synthase. FEBS Lett. 291: 145-149, 1991.
28. Salvemini, D., R. Korbut, E. Anggard, and J. R. Vane. Immediate release of nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 87: 2593-2597, 1990.
29. 2 delivery from experimental data: sensitivity to error. J. Appl. Physiol. 64: 2074-2082, 1988.
30. 2 supply dependence. J. Appl. Physiol. 72: 1499-1505, 1992.
31. 2 extraction during endotoxemia: role of nitric oxide synthesis. Am. J. Respir. Crit. Care Med. 151: 107-115, 1995.
32. Spain, D. A., M. A. Wilson, I. T. M. Bloom, and R. N. Garrison. Renal microvascular responses to sepsis are dependent on nitric oxide. J. Surg. Res. 56: 524-529, 1994.
33. Vallet, B., S. E. Curtis, M. J. Winn, C. E. King, C. K. Chapler, and S. M. Cain. Hypoxic vasodilation does not require nitric oxide (EDRF/NO) synthesis. J. Appl. Physiol. 76: 1256-1261, 1994.
34. Van Dervort, A. L., L. Yan, P. J. Madara, J. P. Cobb, R. A. Wesley, C. C. Corriveau, M. M. Tropea, and R. L. Danner. Nitric oxide regulates endotoxin-induced TNF-α production by human neutrophils. J. Immunol. 152: 4102-4109, 1994.
35. Vincent, J.-L., G. Colice, R. Grover, D. Zaccardelli, K. Guntupalli, and D. Watson. The effects of 546C88 on left ventricular performance in patients with septic shock (Abstract). Intensive Care Med. 21, Suppl.: S20, 1995.
36. Walker, T. A., S. E. Curtis, C. E. King-Van Vlack, C. K. B. Vallet, and S. M. Cain. Effects of nitric oxide synthase inhibition on regional hemodynamics and oxygen transport in endotoxic dogs. Shock 4: 415-420, 1995.
37. Ward, M. E., and S. N. A. Hussain. Effect of inhibition of nitric oxide release on the diaphragmatic oxygen delivery-consumption relationship. J. Crit. Care 9: 90-99, 1994.
38. Wright, C. E., D. D. Rees, and S. Moncada. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26: 48-57, 1992.
39. Zhang, H., D. N. Nguyen, H. Spapen, M. Moock, F. Maciel, and J.-L. Vincent. Sodium nitroprusside does not influence tissue oxygen extraction capabilities during a critical reduction in oxygen delivery. Cardiovasc. Res. 30: 240-245, 1995.
40. Zhang, H., H. Spapen, D. N. Nguyen, M. Benlabed, W. A. Buurman, and J.-L. Vincent. Protective effects of N-acetyl-L-cysteine in endotoxemia. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1746-H1754, 1994.
41. Zhang, H., P. Rogiers, H. Spapen, G. Friedman, J.-C. Preiser, and J.-L. Vincent. Effects of nitric oxide donor SIN-1 on oxygen availability and regional blood flow during endotoxic shock. Arch. Surg. 131: 767-774, 1996.